DEPO-PROVERA (medroxyprogesterone acetate)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 ADVERSE REACTIONS General Disorders and Administration Site Condition:  (addition to this section) injection site...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts